Fund Name | Location |
ALZIS | - |
Chungdahm Learning | Seoul, Seoul-t'ukpyolsi, South Korea |
comScore | Reston, United States, Virginia |
Continuum Group | Newtown Square, Pennsylvania, United States |
EPIC Private Equity | England, London, United Kingdom |
Euroventures | Budapest, Hungary |
George Kaiser Family Foundation | Oklahoma, Tulsa, United States |
Halloran Philanthropies | Dayton, Ohio, United States |
Hangzhou Fuzhuo Investment Management | China, Hangzhou, Zhejiang |
Kuwait Life Sciences Company | Al Kuwayt, Kuwait, Safat |
MARCOL Health | England, London, United Kingdom |
MG Group | India, Maharashtra, Mumbai |
Morton Cohn Investments | Houston, Texas, United States |
NexStreaming | Seoul, Seoul-t'ukpyolsi, South Korea |
OPENSAUCE | Ishikawa Prefecture, Japan, Kanazawa |
Orchid Asia Group Management | China, Hong Kong, Hong Kong Island |
Spring Tide | Texas, Texas City, United States |
Starboard Capital Partners | Connecticut, Southport, United States |
Tigerlabs | New Jersey, Princeton, United States |
Virtu Financial | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Suzhou Pelotin Biotechnology | 07 Jun 2024 | Suzhou, Jiangsu, China | |||
Luxet | 16 Apr 2024 | Suzhou, Jiangsu, China | |||
Luohua Biotechnology | 01 Mar 2024 | Hefei, Anhui, China | |||
Wiserscope | 04 Jan 2024 | Guangzhou, Guangdong, China | |||
Timesintelli | 14 Jul 2023 | Shanghai, Shanghai, China | |||
Shengshi Technology | $15M | 05 Jan 2022 | Hangzhou, Zhejiang, China | ||
Beion Medical | $1M | 29 Dec 2021 | Shanghai, Shanghai, China | ||
ReadCrystal | 24 Sep 2021 | Suzhou, Jiangsu, China | |||
Suzhou Pelotin Biotechnology | 01 Jan 2020 | Suzhou, Jiangsu, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Suzhou Pelotin Biotechnology | 07 Jun 2024 | Suzhou, Jiangsu, China | |||
Luxet | 16 Apr 2024 | Suzhou, Jiangsu, China | |||
Luohua Biotechnology | 01 Mar 2024 | Hefei, Anhui, China | |||
Wiserscope | 04 Jan 2024 | Guangzhou, Guangdong, China | |||
Timesintelli | 14 Jul 2023 | Shanghai, Shanghai, China | |||
Shengshi Technology | $15M | 05 Jan 2022 | Hangzhou, Zhejiang, China | ||
Beion Medical | $1M | 29 Dec 2021 | Shanghai, Shanghai, China | ||
ReadCrystal | 24 Sep 2021 | Suzhou, Jiangsu, China | |||
Suzhou Pelotin Biotechnology | 01 Jan 2020 | Suzhou, Jiangsu, China |